BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10063210)

  • 1. Juvenile chronic myelogenous leukemia, neurofibromatosis 1, and xanthoma.
    Jang KA; Choi JH; Sung KJ; Moon KC; Koh JK; Im DJ
    J Dermatol; 1999 Jan; 26(1):33-5. PubMed ID: 10063210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Juvenile chronic granulocytic leukemia, juvenile xanthogranulomas, and neurofibromatosis. Case report and review of the literature.
    Morier P; Mérot Y; Paccaud D; Beck D; Frenk E
    J Am Acad Dermatol; 1990 May; 22(5 Pt 2):962-5. PubMed ID: 2110580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Juvenile xanthogranuloma, neurofibromatosis, and juvenile chronic myelogenous leukemia. World statistical analysis.
    Zvulunov A; Barak Y; Metzker A
    Arch Dermatol; 1995 Aug; 131(8):904-8. PubMed ID: 7632061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 mutation as the second event in juvenile chronic myelogenous leukemia in a patient with neurofibromatosis type 1.
    Luria D; Avigad S; Cohen IJ; Stark B; Weitz R; Zaizov R
    Cancer; 1997 Nov; 80(10):2013-8. PubMed ID: 9366306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosome pattern in juvenile chronic myelogenous leukemia, myelodysplastic syndrome, and acute leukemia associated with neurofibromatosis.
    Kaneko Y; Maseki N; Sakurai M; Shibuya A; Shinohara T; Fujimoto T; Kanno H; Nishikawa A
    Leukemia; 1989 Jan; 3(1):36-41. PubMed ID: 2491896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Juvenile myelomonocytic leukaemia, xanthoma, and neurofibromatosis type 1].
    Benessahraoui M; Aubin F; Paratte F; Plouvier E; Humbert P
    Arch Pediatr; 2003 Oct; 10(10):891-4. PubMed ID: 14550978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circinate plaques heralding juvenile chronic myelogenous leukemia.
    Buescher L; Anderson PC
    Pediatr Dermatol; 1990 Jun; 7(2):122-5. PubMed ID: 2359727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of hematopoietic lineage involvement in children with neurofibromatosis type 1 and malignant myeloid disorders.
    Miles DK; Freedman MH; Stephens K; Pallavicini M; Sievers EL; Weaver M; Grunberger T; Thompson P; Shannon KM
    Blood; 1996 Dec; 88(11):4314-20. PubMed ID: 8943868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent annular erythema in juvenile chronic myelogenous leukaemia.
    Anzai H; Kikuchi A; Kinoshita A; Nishikawa T
    Br J Dermatol; 1998 Jun; 138(6):1058-60. PubMed ID: 9747374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hereditary hematopoietic malignancy with emphasis of juvenile chronic myelogenous leukemia and 7 monosomy syndrome].
    Hayashi Y
    Nihon Rinsho; 1995 Nov; 53(11):2737-41. PubMed ID: 8538036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Juvenile xanthogranuloma, neurofibromatosis, and juvenile chronic myelogenous leukemia.
    Zvulunov A
    Arch Dermatol; 1996 Jun; 132(6):712-3. PubMed ID: 8651728
    [No Abstract]   [Full Text] [Related]  

  • 12. Monosomy 7 myeloproliferative disease associated with neurofibromatosis type I: a case report.
    Savasan S; Zülfikar B; Ozgeneci A; Ozbek U; Sengün Z
    J Chemother; 1996 Jun; 8(3):243-6. PubMed ID: 8808725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffuse plane xanthoma in a patient with chronic myeloid leukemia.
    Kim KJ; Lee DP; Suh HS; Lee MW; Choi JH; Moon KC; Koh JK
    J Dermatol; 2004 Jun; 31(6):503-5. PubMed ID: 15235195
    [No Abstract]   [Full Text] [Related]  

  • 14. Cutaneous presentation of juvenile chronic myelogenous leukemia: a diagnostic and therapeutic dilemma.
    Sires UI; Mallory SB; Hess JL; Keating JP; Bloomberg G; Dehner LP
    Pediatr Dermatol; 1995 Dec; 12(4):364-8. PubMed ID: 8747588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of heterozygosity of NF1 gene in juvenile chronic myelogenous leukemia with neurofibromatosis type 1.
    Kai S; Sumita H; Fujioka K; Takahashi H; Hanzawa N; Funabiki T; Ikuta K; Sasaki H
    Int J Hematol; 1998 Jul; 68(1):53-60. PubMed ID: 9713168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of neurofibromatosis type 1 gene mutation in juvenile chronic myelogenous leukemia.
    Watanabe I; Horiuchi T; Hatta N; Matsumoto M; Koike K; Kojima S; Ohga S; Fujita S
    Acta Haematol; 1998; 100(1):22-5. PubMed ID: 9691142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin, blood, nerve cells, and heritability. New lessons from neurofibromatosis type 1.
    Riccardi VM
    Arch Dermatol; 1995 Aug; 131(8):944. PubMed ID: 7632067
    [No Abstract]   [Full Text] [Related]  

  • 18. Juvenile chronic myelogenous leukemia and neurofibromatosis in infancy presenting as ocular hemorrhage.
    Shaw NJ; Eden OB
    Pediatr Hematol Oncol; 1989; 6(1):23-6. PubMed ID: 2641696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ultrastructural study in four cases of cutaneous xanthomas in children (author's transl)].
    Schnitzler L; Verret JL
    Ann Dermatol Venereol; 1979 Mar; 106(3):243-7. PubMed ID: 225978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Juvenile chronic myelogenous leukemia.
    Hess JL; Zutter MM; Castleberry RP; Emanuel PD
    Am J Clin Pathol; 1996 Feb; 105(2):238-48. PubMed ID: 8607451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.